Breaking News Instant updates and real-time market news.

RDUS

Radius Health

$52.10

0.5 (0.97%)

, SHPG

Shire

$197.70

3.2 (1.65%)

07:50
10/11/16
10/11
07:50
10/11/16
07:50

Shire nearing 'multi-billion dollar' deal to buy Radius Health, Betaville says

Shire (SHPG) is near to agreeing to a "multi-billion dollar" acquisition of Radius Health (RDUS), according to Ben Harrington's Betaville blog. Shares of Radius Health, which has been the subject of several prior takeover rumors, are up 3.5% in early trading. Reference Link

RDUS

Radius Health

$52.10

0.5 (0.97%)

SHPG

Shire

$197.70

3.2 (1.65%)

  • 06

    Nov

RDUS Radius Health
$52.10

0.5 (0.97%)

08/04/16
08/04/16
DOWNGRADE

Sell
Followup: Radius Health downgraded to Sell from Hold at Maxim
As previously reported, Maxim downgraded Radius Health to Sell from Hold with a $24 price target. Analyst Jason McCarthy believes Radius shares are overvalued and continues to believe that Abaloparatide-SC will likely gain approval in 2017 in both the U.S. and Europe, but faces a mature Forteo market, competition from Biosimilar Forteo in 2018, and patients opting for alternative therapies.
08/15/16
JEFF
08/15/16
NO CHANGE
Target $46
JEFF
Hold
Radius Health price target raised to $46 from $37 at Jefferies
Jefferies analyst Eun Yang raised her price target for Radius Health to $46 but keeps a Hold rating on the shares. The analyst says her firm's physician poll shows convenient abalo-TD patch for osteoporosis, if successful, would increase abalo use by 25%-30%. Yang adds that while she isn't taking a "strong view" on recent M&A speculation, some of rumored buyers for Radius "don't seem a right fit."
09/21/16
HCWC
09/21/16
NO CHANGE
Target $71
HCWC
Buy
Radius Health price target raised to $71 from $55 at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther raised her price target for Radius Health to $71 saying results of the second generation transdermal patch in postmenopausal women are promising. ABL-TD patch could not only replace the anabolic drugs on the market, it could expand the market "significantly," Werther tells investors in a research note. She keeps a Buy rating on Radius.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
SHPG Shire
$197.70

3.2 (1.65%)

08/03/16
LEER
08/03/16
NO CHANGE
Target $231
LEER
Outperform
Shire price target raised to $231 from $213 at Leerink
Leerink analyst Jason Gerberry raised his price target for Shire to $231 from $213 on valuation after the company reported "solid" Q2 results. The analyst reiterates an Outperform rating on the shares.
08/31/16
JEFF
08/31/16
NO CHANGE
Target $262
JEFF
Buy
Shire making right moves in dry eye market, says Jefferies
After hosting meetings with management, Jefferies analyst David Steinberg believes Shire (SHPG) is making "all the right moves" to make its dry eye drug Xiidra a potential $2B peak product in the U.S. Shire's Xiidra is competing with Allergan's (AGN) $1.4B dry eye drug Restasis, Steinberg tells investors in a research note. The analyst does not think Shire will have any problem exceeding the drug's consensus sales forecast of $200M for next year. He keeps a Buy rating on the shares with a $262 price target.
09/26/16
HSBC
09/26/16
DOWNGRADE
HSBC
Hold
Shire downgraded to Hold from Buy at HSBC
HSBC analyst Steve McGarry downgraded SHire to Hold saying valuation is no longer compelling.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.

TODAY'S FREE FLY STORIES

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

, CST

CST Brands

$48.53

-0.01 (-0.02%)

18:19
06/27/17
06/27
18:19
06/27/17
18:19
Hot Stocks
Alimentation Couche-Tard cleared in Canada for acquisition of CST Brands »

Alimentation Couche-Tard…

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

CST

CST Brands

$48.53

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSLI

Merus Labs

$1.23

-0.0015 (-0.12%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Merus Labs reminds shareholders to vote for arrangement with Norgine »

Merus Labs International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGI

Endurance

$8.20

-0.15 (-1.80%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Endurance chief administration officer Andreasen to leave company »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$186.97

0.68 (0.37%)

17:41
06/27/17
06/27
17:41
06/27/17
17:41
Hot Stocks
Huntington Ingalls receives contract modifications to incorporate upgrades »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$56.18

-0.55 (-0.97%)

17:34
06/27/17
06/27
17:34
06/27/17
17:34
Hot Stocks
International Paper agrees to settle Kleen Products class action litigation »

International Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUSA

Houston American Energy

$0.67

0.0385 (6.10%)

17:33
06/27/17
06/27
17:33
06/27/17
17:33
Syndicate
Houston American Energy requests withdrawal of registration statement »

The company determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$22.82

0.04 (0.18%)

, RYI

Ryerson

$9.00

-0.1 (-1.10%)

17:24
06/27/17
06/27
17:24
06/27/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: KB…

KBH

KB Home

$22.82

0.04 (0.18%)

RYI

Ryerson

$9.00

-0.1 (-1.10%)

AVAV

AeroVironment

$32.49

1.52 (4.91%)

CAMP

CalAmp

$19.25

-0.37 (-1.89%)

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

WLL

Whiting Petroleum

$5.48

0.04 (0.74%)

OAS

Oasis Petroleum

$7.93

0.21 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 03

    Jul

  • 04

    Jul

  • 05

    Jul

  • 28

    Jun

CHKE

Cherokee

17:22
06/27/17
06/27
17:22
06/27/17
17:22
Hot Stocks
Breaking Hot Stocks news story on Cherokee »

Cherokee says announcing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

KBH

KB Home

$22.82

0.04 (0.18%)

17:16
06/27/17
06/27
17:16
06/27/17
17:16
Hot Stocks
KB Home sees Q3 housing revenue $1.08B-$1.15B »

Sees Q3 average selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

KBH

KB Home

$22.82

0.04 (0.18%)

17:16
06/27/17
06/27
17:16
06/27/17
17:16
Hot Stocks
KB Home raises FY17 housing revenue view to $4.2B-$4.4B from $4B-$4.3B »

Sees FY17 average selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

17:15
06/27/17
06/27
17:15
06/27/17
17:15
General news
Breaking General news story  »

Minneapolis Federal…

CHKE

Cherokee

17:13
06/27/17
06/27
17:13
06/27/17
17:13
Hot Stocks
Cherokee receives listing notice over late 10-Q »

Cherokee announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

BEP

Brookfield Renewable

$33.03

0.1 (0.30%)

, BAM

Brookfield

$39.47

0.33 (0.84%)

17:13
06/27/17
06/27
17:13
06/27/17
17:13
Syndicate
Brookfield Renewable files to sell 8.3M L.P. units on bought deal basis »

Brookfield Renewable…

BEP

Brookfield Renewable

$33.03

0.1 (0.30%)

BAM

Brookfield

$39.47

0.33 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$121.59

-0.28 (-0.23%)

17:11
06/27/17
06/27
17:11
06/27/17
17:11
Hot Stocks
United Technologies responds to reports regarding Carrier manufacturing facility »

In response to recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPTN

SpartanNash

$25.30

0.22 (0.88%)

17:07
06/27/17
06/27
17:07
06/27/17
17:07
Hot Stocks
SpartanNash says CFO Meyers resigns »

SpartanNash disclosed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARO

FARO Technologies

$36.10

-0.65 (-1.77%)

17:06
06/27/17
06/27
17:06
06/27/17
17:06
Initiation
FARO Technologies initiated  »

FARO Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$14.98

-0.03 (-0.20%)

17:05
06/27/17
06/27
17:05
06/27/17
17:05
Hot Stocks
Monmouth Real Estate acquires South Carolina industrial building for $22M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

WDC

Western Digital

$91.85

-0.81 (-0.87%)

, TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

17:03
06/27/17
06/27
17:03
06/27/17
17:03
Hot Stocks
Western Digital announces new 3D NAND technology, touts strength in Japan JV »

Western Digital (WDC)…

WDC

Western Digital

$91.85

-0.81 (-0.87%)

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDP

Fresh Del Monte

$49.98

-0.19 (-0.38%)

17:03
06/27/17
06/27
17:03
06/27/17
17:03
Hot Stocks
Fresh Del Monte and Del Monte Pacific announce series of joint ventures »

Del Monte Pacific and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$48.50

-0.28 (-0.57%)

, ALOG

Analogic

$68.15

-0.85 (-1.23%)

17:03
06/27/17
06/27
17:03
06/27/17
17:03
Hot Stocks
American Airlines, Analogic announce partnership to improve aviation security »

American Airlines (AAL)…

AAL

American Airlines

$48.50

-0.28 (-0.57%)

ALOG

Analogic

$68.15

-0.85 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

DOW

Dow Chemical

$63.09

-0.48 (-0.76%)

, DD

DuPont

$80.69

-0.47 (-0.58%)

16:59
06/27/17
06/27
16:59
06/27/17
16:59
Hot Stocks
Canada Competition Bureau reaches agreement with DuPont, Dow Chemical on merger »

Canada's Competition…

DOW

Dow Chemical

$63.09

-0.48 (-0.76%)

DD

DuPont

$80.69

-0.47 (-0.58%)

FMC

FMC Corporation

$74.01

-0.76 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

16:47
06/27/17
06/27
16:47
06/27/17
16:47
Hot Stocks
Global Medical REIT provides update on acquisition of cardiac clinic in Lubbok »

Global Medical REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:46
06/27/17
06/27
16:46
06/27/17
16:46
Hot Stocks
Ryerson comments on Q2 market conditions, demand environment »

In a press release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:43
06/27/17
06/27
16:43
06/27/17
16:43
Earnings
Ryerson sees Q2 net income $0M-$2M »

EPS consensus 35c. Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
06/27/17
06/27
16:38
06/27/17
16:38
General news
API crude inventories for week of June 23 »

API reports that crude…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.